Jazz Pharmaceuticals JAZZ Invested capital
Discontinued — last reported Q1 '26
Invested capital at other companies
Other financials
Where this comes from
Calculated from Jazz Pharmaceuticals’s reported figures.
The official record: Jazz Pharmaceuticals’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Jazz Pharmaceuticals's invested capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Jazz Pharmaceuticals's invested capital?
- Jazz Pharmaceuticals (JAZZ) reported invested capital of $9.27B in Q1 2026.
- How has Jazz Pharmaceuticals's invested capital changed year-over-year?
- Jazz Pharmaceuticals's invested capital increased by 20.0% year-over-year, from $7.72B to $9.27B.
- What is the long-term trend for Jazz Pharmaceuticals's invested capital?
- Over 5 years (2020 to 2025), Jazz Pharmaceuticals's invested capital has grown at a 13.3% compound annual growth rate (CAGR), from $4.85B to $9.06B.
- What does invested capital mean?
- The capital — debt plus equity, net of idle cash — that funds the operating business.
- How do you interpret invested capital?
- A level, read mainly through ROIC (NOPAT ÷ invested capital). Growing invested capital is only good if returns on it stay above the cost of capital.
- How does invested capital compare across companies?
- Used as the base for ROIC; the definition is sector-sensitive, so banks and insurers are best excluded.